Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Condition:   Cervical CancerInterventions:   Drug: Hydralazine/Magnesium;   Drug: Placebo;   Drug: Carboplatin;   Drug: PaclitaxelSponsors:   National Institute of Cancerología;   Psicofarma S.A. de C.V.Not yet recruiting - verified May 2015

Source: ClinicalTrials.gov - April 20, 2015 Category: Research Source Type: clinical trials